Mehrdad Rakaee
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 18
- Cancer Cells and Metastasis 5
- Immunology top 5%
- Immune cells in cancer 6
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 5
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 6
- Prostate Cancer Treatment and Research 6
-
- Radiomics and Machine Learning in Medical Imaging 4
- Co-authors
- Tom DønnemRoy M. BremnesLill‐Tove BusundSigve AndersenElin RichardsenThomas K. KilværSamer Al‐SaadErna‐Elise Paulsen
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- NorwayUnited StatesUnited Kingdom
In The Last Decade
Mehrdad Rakaee
38 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 89
- Oncology 969
- Immunology 543
- Cancer Research 371
- Pulmonary and Respiratory Medicine 572
- Molecular Biology 485
Countries citing papers authored by Mehrdad Rakaee
This map shows the geographic impact of Mehrdad Rakaee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehrdad Rakaee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehrdad Rakaee more than expected).
Fields of papers citing papers by Mehrdad Rakaee
This network shows the impact of papers produced by Mehrdad Rakaee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehrdad Rakaee. The network helps show where Mehrdad Rakaee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mehrdad Rakaee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 7 | |
| 5 | 2021 | 31 | |
| 6 | 2019 | 28 | |
| 7 | 2019 | 119 | |
| 8 | 2019 | 46 | |
| 9 | 2018 | 43 | |
| 10 | 2018 | 54 | |
| 11 | 2018 | 32 | |
| 12 | 2017 | 2 | |
| 13 | 2017 | 58 | |
| 14 | 2017 | 57 | |
| 15 | 2017 | 71 | |
| 16 | 2017 | 39 | |
| 17 | 2016 | 72 | |
| 18 | 2016 | 32 | |
| 19 | 2016 | 362 | |
| 20 | 2015 | 73 |
About Mehrdad Rakaee
Mehrdad Rakaee is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), Immune cells in cancer (6 papers), Prostate Cancer Treatment and Research (6 papers), Cancer Cells and Metastasis (5 papers), Cancer Genomics and Diagnostics (5 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). The work is most often cited by research in Oncology (969 citations), Immunology (543 citations) and Cancer Research (371 citations). Mehrdad Rakaee has collaborated with scholars based in Norway, United States and United Kingdom. Frequent co-authors include Tom Dønnem, Roy M. Bremnes, Lill‐Tove Busund, Sigve Andersen, Elin Richardsen, Thomas K. Kilvær, Samer Al‐Saad, Erna‐Elise Paulsen, Sigurd M. Hald and Nora Ness. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.